Collegium Pharmaceutical
COLL
COLL
150 hedge funds and large institutions have $648M invested in Collegium Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
150
Holders Change
-9
Holders Change %
-5.66%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
60
Reduced
55
Closed
26
Calls
$2.54M
Puts
$579K
Net Calls
+$1.96M
Net Calls Change
+$1.67M
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$12.5M |
| 2 |
PA
Perceptive Advisors
New York
|
+$8.86M |
| 3 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$7.28M |
| 4 |
BlackRock
New York
|
+$5.58M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$3.67M |
Top Sellers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$7.3M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.16M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$3.93M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$3.28M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$2.89M |
